Juniper and Turk Telekom Join Forces to Create Open RAN 5G Ecosystem
shot by IP News Shots / 6:32 pm on 20 January, 2021
A technology and commercial partnership has been established between Juniper Networks Inc. and the Turk Telekom Group for the development of an Open RAN 5G ecosystem. The partnership will include an exclusive global licensing deal with a subsidiary of Turk Telekom, Netsia to give access to its Radio Intelligent Controller (RIC) technology including related source code and patents.
Mogrify to Gain Access to IP Developed During Exploratory Research Project with MRC LMB
shot by IP News Shots / 6:29 pm on 12 January, 2021
Mogrify Limited and MRC Laboratory of Molecular Biology have entered into exploratory research collaboration for the development of new protein expression systems by using recent innovations in direct cell reprogramming. Any intellectual property (IP) as well as know-how developed during the collaboration will be accessed by Mogrify for commercialization of technology in therapeutic applications.
shot by IP News Shots / 8:39 pm on 06 January, 2021
Avingtrans Plc, a majority stakeholder in Scientific Magnetics will be acquiring a majority of shares in a merger involving Scientific Magnetics, its subsidiary Tecmag Inc. and Magnetica Pty Ltd. The merger that will result in a company by the name Magnetica, will be strengthened with a comprehensive product portfolio and will also get access to the core intellectual property of Scientific Magnetics and Tecmag.
SpiceJet to Use PLUSS’ Celsure for COVID-19 Vaccine Delivery
shot by IP News Shots / 6:04 pm on 31 December, 2020
SpiceJet Limited has signed a Memorandum of Understanding (MoU) with Pluss Advanced Technologies (PLUSS) to receive a supply of their patent-protected product ‘Celsure’. The product will be used in the last mile delivery of the highly-sensitive COVID-19 vaccines which require extremely precise transportation and storage conditions to retain effectiveness.
Pluristem and Innovare Join Hands to Expand Clinical Program of PLX Cells in ARDS Treatment
shot by IP News Shots / 6:20 pm on 30 December, 2020
Pluristem Therapeutics Inc. and Innovare R&D have signed a collaboration agreement to expand the former’s clinical program for use of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related to COVID-19. Innovare will be responsible for the logistics as well as the clinical trials. It will also fund the study which will be carried out with the PLX cells purchased from Pluristem. As per the agreement, Innovare will get exclusive distribution rights for the supply of PLX cells in the treatment of COVID-19, subject to positive trial results and regulatory approvals. The intellectual property and manufacturing rights will remain with Pluristem.
shot by IP News Shots / 5:53 pm on 30 December, 2020
The Valencian International University (VIU) has awarded a contract to Lleida.net to use their proprietary eKYC Onboarding platform in the process of on-boarding via videoconferencing after completion of identification.
Your one stop source for the latest IP happenings around the world
Sign up now to avail:
Access unlimited IP news related to multiple industries and stay updated on the go. We offer summaries of the latest and most relevant IP news from around the world in less than 100 words.
Custom News Feed
If you don't want to read an endless list of news, just select industries and news categories that you want under Your Interest section to create a personalized feed – My Feed and view news that suits your needs.
Weekly News Roundup
As a bonus, registered users will receive a Weekly roundup of Top IP news.